Mycoplasma chlamydia pneumonia treatment cycle

Mycoplasma pneumonia is an acute infectious lesion of the respiratory tract caused by Mycoplasma pneumoniae, which can manifest as asymptomatic infection, upper respiratory tract infection, tracheobronchitis, and pneumonia; Chlamydia pneumoniae mainly causes respiratory and lung infections.Both mycoplasma and chlamydia are intracellular bacteria that are resistant to antibiotics acting on the cell wall, such as β-lactams, due to the lack of a cell wall, and are susceptible to the following: tetracyclines, such as doxycycline, minocycline; macrolides, such as erythromycin, azithromycin, clarithromycin; Quinolones, such as levofloxacin, moxifloxacin. Tetracyclines and quinolones are not recommended for children. The treatment cycles of mycoplasma pneumonia and chlamydia pneumonia are as follows: 1. The treatment course of mycoplasma pneumonia is generally 7~14 days, and the treatment course of some refractory cases can be extended to about 3 weeks, but it is not appropriate to take the complete absorption of lung shadow as an indication for stopping antimicrobial drugs. 2. Patients with chlamydia pneumoniae infection have a tendency to recur, so the duration of antibiotic treatment should be appropriately extended. For adults, a total of 2~3 weeks, for children, erythromycin or clarithromycin suspension is used, and the course of treatment is 10~14 days. If cough or other respiratory symptoms persist after one course, another course of treatment may be given.